GW Pharmaceuticals is a pioneering biopharmaceutical company with a focus on cannabinoid science and developing approved medicines derived from cannabis to improve the lives of seriously ill patients and their families. Over the course of two decades, the UK-based company has established itself as a world leader in this field, driving innovation in the industry. Their achievements led to recognition by TIME Magazine, who listed them as one of the 'Top 50 Genius Companies of 2018 that are inventing the future'.